vedolizumab - CISMeF

Preferred Label : vedolizumab;

MeSH note : a humanized monoclonal antibody that targets the 4beta7 integrin exclusively, and modulates inflammation in the gastrointestinal tract;

CISMeF synonym : MLN0002;

MeSH hyponym : MLN02; MLN-0002; MLN-02;

Is substance : O;

UNII : 9RV78Q2002;

Details

Origin ID

C543529;

UMLS CUI

C2742797;

ATC code(s)
- vedolizumab [ATC Code]
CISMeF manual mappings
- Vedolizumab (substance) [SNOMED CT concept]
Currated CISMeF NLP mapping
- Vedolizumab [LOINC component]
- Vedolizumab [SMS substance]
- Vedolizumab [ICD-11 Extension code]
- Vedolizumab [Anticorps monoclonal]
- Vedolizumab [NCIt concept]
- vedolizumab [International Nonproprietary Name]
Exact mapping(s) to DCI
- vedolizumab [International Nonproprietary Name]
MeSH term(s) associated for indexing
- antibodies, monoclonal, humanized [MeSH Descriptor]
Pharmacological action(s)
- gastrointestinal agents [MeSH Descriptor]
Record concept(s)
- Entyvio [MeSH concept]
- MLN0002 [MeSH concept]
- vedolizumab [MeSH concept]
See also inter- (CISMeF)
- Product containing vedolizumab (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Product containing vedolizumab (medicinal product) [SNOMED CT concept]
- Vedolizumab [LOINC component]
- Vedolizumab [NCIt concept]
- Vedolizumab (substance) [SNOMED CT concept]
- vedolizumab [ATC Code]
- vedolizumab [International Nonproprietary Name]
Validated automatic mappings to BTNT
- vedolizumab [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients